CHARACTERIZE MAMMALIAN TRANSCRIPTOME COMPLEXITY: FROM GENOMEWIDE RTPCR CDNA CLONING, TO NOVEL MAMMALIAN GENE DISCOVERY, AND TR,Used

CHARACTERIZE MAMMALIAN TRANSCRIPTOME COMPLEXITY: FROM GENOMEWIDE RTPCR CDNA CLONING, TO NOVEL MAMMALIAN GENE DISCOVERY, AND TR,Used

In Stock
SKU: DADAX3844320601
Brand: LAP Lambert Academic Publishing
Sale price$149.37 Regular price$213.39
Save $64.02
Quantity
Add to wishlist
Add to compare

Processing time: 1-3 days

US Orders Ships in: 3-5 days

International Orders Ships in: 8-12 days

Return Policy: 15-days return on defective items

Payment Option
Payment Methods

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

In my Ph.D. thesis, I described a large scale RTPCR and cloning pipeline that I developed to obtain several thousand fulllength mammalian (mainly human and mouse) cDNA clones for the NHGRI/NCI Mammalian Gene Collection effort. At that time, the layers of the mammalian transcriptome complexity were not yet fully conceived. In this project, I was deeply involved in strategic and conceptual issues in characterizing transcriptome complexity from different levels. Using the RTPCR pipeline combined with gene prediction algorithms that utilize comparative genomic information, we successfully identified and experimentally verified novel mammalian genes such as fulllength rat homologs of human disease genes. Furthermore, I studied transcriptome complexity including SNPs and alternative splicing in leukemia samples using quantitative PCR, and we developed a trace analysis technology to identify multiple alternative spliced transcripts in one single sequencing reaction. My results suggested that alternatively spliced transcripts show cancer type specific up or down regulation, and the ratio of alternative spliced isoforms may underlie the cancer mechanism.

⚠️ WARNING (California Proposition 65):

This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.

For more information, please visit www.P65Warnings.ca.gov.

Recently Viewed